TCT-467 Comparison biolimus- and everolimus-eluting stents in patients with small vessels disease. Five year follow-up from the COMPARE II trial

Drug eluting stents with biodegradable polymer have been developed to address the risk of very late adverse events. COMPARE II is one of the largest randomized studies comparing the biodegradable polymer-coated biolimus-eluting stent (BES; Nobori®) with second-generation durable polymer-coated